Free Trial

Fennec Pharmaceuticals (FENC) SEC Filings & 10K Form

Fennec Pharmaceuticals logo
$5.02 +0.38 (+8.19%)
(As of 01:30 PM ET)

Recent Fennec Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/18/2024
4:02 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:13 PM
Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:14 PM
Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:15 PM
Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
6:38 PM
DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
3:46 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
4:30 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:30 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:00 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:14 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:11 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:13 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:02 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:33 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:48 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:30 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4/A
08/26/2024
4:51 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:59 PM
Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:00 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:00 PM
Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:01 PM
Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:02 PM
Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:56 PM
Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
4:10 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:30 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:21 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:55 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:42 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:43 PM
DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G
06/03/2024
5:21 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:12 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:05 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:05 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:05 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:24 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:42 PM
Fennec Pharmaceuticals (Filer)
Form DEF 14A
05/02/2024
3:59 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:15 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4/A
04/22/2024
6:34 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:21 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2024
8:43 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

04/18/2024
3:24 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:23 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
5:00 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:15 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
5:15 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:28 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
3:19 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
3:46 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
4:37 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:55 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:00 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:14 PM
Fennec Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
3:22 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:24 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:43 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
6:31 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:05 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
2:53 PM
Fennec Pharmaceuticals (Filer)
Form 424B7
01/05/2024
4:24 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:45 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:42 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:30 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
2:51 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2023
11:15 PM
Fennec Pharmaceuticals (Filer)
Form EFFECT
12/05/2023
7:51 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
8:20 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FENC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners